Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-16

FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Novugen Pharma (USA) LLC)

View source ↗

Summary

FDA approved the original application for a generic Sacubitril and Valsartan product by Novugen Pharma (USA) LLC, enabling a generic version of the heart failur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacubitril and valsartan (sacubitril/valsartan)

Snippet

ORIG AP for SACUBITRIL AND VALSARTAN (SACUBITRIL AND VALSARTAN)